Stefkó, D.; Kúsz, N.; Szemerédi, N.; Barta, A.; Spengler, G.; Berkecz, R.; Hohmann, J.; Vasas, A.
Unique Phenanthrenes from Juncus ensifolius and Their Antiproliferative and Synergistic Effects with the Conventional Anticancer Agent Doxorubicin against Human Cancer Cell Lines. Pharmaceutics 2022, 14, 608.
https://doi.org/10.3390/pharmaceutics14030608
AMA Style
Stefkó D, Kúsz N, Szemerédi N, Barta A, Spengler G, Berkecz R, Hohmann J, Vasas A.
Unique Phenanthrenes from Juncus ensifolius and Their Antiproliferative and Synergistic Effects with the Conventional Anticancer Agent Doxorubicin against Human Cancer Cell Lines. Pharmaceutics. 2022; 14(3):608.
https://doi.org/10.3390/pharmaceutics14030608
Chicago/Turabian Style
Stefkó, Dóra, Norbert Kúsz, Nikoletta Szemerédi, Anita Barta, Gabriella Spengler, Róbert Berkecz, Judit Hohmann, and Andrea Vasas.
2022. "Unique Phenanthrenes from Juncus ensifolius and Their Antiproliferative and Synergistic Effects with the Conventional Anticancer Agent Doxorubicin against Human Cancer Cell Lines" Pharmaceutics 14, no. 3: 608.
https://doi.org/10.3390/pharmaceutics14030608
APA Style
Stefkó, D., Kúsz, N., Szemerédi, N., Barta, A., Spengler, G., Berkecz, R., Hohmann, J., & Vasas, A.
(2022). Unique Phenanthrenes from Juncus ensifolius and Their Antiproliferative and Synergistic Effects with the Conventional Anticancer Agent Doxorubicin against Human Cancer Cell Lines. Pharmaceutics, 14(3), 608.
https://doi.org/10.3390/pharmaceutics14030608